LQDA

Liquidia Technologies Inc. is a leading biopharmaceutical company located in Morrisville, North Carolina, specializing in innovative therapies to meet significant unmet medical needs. The company employs its proprietary PRINT technology for the precision manufacturing of drug particles, enhancing both targeted delivery and therapeutic efficacy. With a strong pipeline focused on treating pulmonary hypertension and other serious conditions, Liquidia underscores its strategic relevance in the biopharmaceutical industry. Committed to improving patient outcomes through technological advancements, Liquidia is well-positioned for continued growth in the dynamic healthcare market.